Skip to main content
Supplement ScienceSupplementScience

Benefits of Beta-Sitosterol

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • BPH symptom relief — a landmark 1995 Lancet RCT (n=200) found 20mg TID beta-sitosterol significantly improved IPSS scores, urinary flow rate (+35%), and post-void residual volume vs placebo over 6 months
  • Cholesterol reduction — plant sterols including beta-sitosterol reduce LDL cholesterol by 6-15% by competing with dietary cholesterol for intestinal absorption, earning an FDA health claim
  • Prostate inflammation — in vitro and animal studies show beta-sitosterol inhibits 5-alpha-reductase and reduces prostaglandin synthesis in prostate tissue
  • Immune modulation — a 2003 study found beta-sitosterol enhanced natural killer cell activity and T-cell proliferation at physiological concentrations

What the Research Says

Beta-Sitosterol is well-supported by evidence for its role in managing benign prostatic hyperplasia (BPH). A systematic review by Wilt et al. (1999), which analyzed four randomized controlled trials involving 519 men, demonstrated that beta-sitosterol significantly improves urologic symptoms and urinary flow measures compared to placebo. The landmark trial by Berges et al. (1995) further solidified these findings, showing a 7.4-point improvement in the International Prostate Symptom Score (IPSS) for beta-sitosterol versus 2.9 points for placebo.

In addition to its effects on BPH, beta-sitosterol has been studied for its cholesterol-lowering properties. A meta-analysis by Abumweis et al. (2008) confirmed that plant sterols, including beta-sitosterol, reduce low-density lipoprotein (LDL) cholesterol by 8-10% when consumed at a dose of 2 grams per day. This finding aligns with the broader evidence supporting the use of plant sterols as effective agents for managing dyslipidemia.

Furthermore, a systematic review by Ulbricht et al. (2016) evaluated clinical trials on beta-sitosterol and sitosterol, concluding that they are both safe and efficacious based on available evidence. These studies collectively highlight the versatility of beta-sitosterol in addressing multiple health concerns, particularly in urologic and cardiovascular contexts.

Related Conditions

Prostate HealthHigh CholesterolHeart Health
Ready to try Beta-Sitosterol?
See our independently tested and ranked picks
Full Beta-Sitosterol Guide

References

  1. RCTBerges RR, Windeler J, Trampisch HJ, Senge T (1995). Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. The Lancet. DOI PubMed
  2. ReviewWilt TJ, MacDonald R, Ishani A (1999). Beta-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review. BJU International. DOI PubMed
  3. RCTKlippel KF, Hiltl DM, Schipp B (1997). A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol for benign prostatic hyperplasia. British Journal of Urology. DOI PubMed
  4. Meta-analysisAbumweis SS, Barake R, Jones PJH (2008). Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials. Food & Nutrition Research. DOI PubMed
  5. ReviewUlbricht CE (2016). An Evidence-Based Systematic Review of Beta-Sitosterol, Sitosterol (22,23- dihydrostigmasterol, 24-ethylcholesterol) by the Natural Standard Research Collaboration.. Journal of dietary supplements. PubMed
  6. Ontawong A, Pengnet S, Thim-Uam A, Munkong N, et al. (2024). A randomized controlled clinical trial examining the effects of Cordyceps militaris beverage on the immune response in healthy adults.. Scientific reports. DOI PubMed
  7. Meng H, Matthan NR, Angellotti E, Pittas AG, et al. (2020). Exploring the effect of vitamin D3 supplementation on surrogate biomarkers of cholesterol absorption and endogenous synthesis in patients with type 2 diabetes-randomized controlled trial.. The American journal of clinical nutrition. DOI PubMed
Show 1 more reference
  1. Ho XL, Loke WM (2017). Dietary Plant Sterols Supplementation Increases In Vivo Nitrite and Nitrate Production in Healthy Adults: A Randomized, Controlled Study.. Journal of food science. DOI PubMed